Perseris

News

Indivior's once-monthly schizophrenia injection gets US gree...

Regulators authorities in the US have approved Indivior’s long-acting injectable treatment for adults with schizophrenia.

News

Madrigal eyes combination MASH therapy with Pfizer deal

Madrigal Pharma is reheating a drug for metabolic dysfunction-associated steatohepatitis (MASH) put on ice by Pfizer last year.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Editor's Picks